カテゴリ： Stratistics MRC, 世界, 医療/バイオ

出血性疾患検査のグローバル市場（～2027）：試薬、消耗品、器具、その他

■ 英語タイトル：Bleeding Disorder Testing Market Forecasts to 2028 – Global Analysis By Product (Reagents, Consumables, Instruments and Other Products), Drug Class (Fibrin Sealants, Desmopressin Acetate, Antifibrinolytics, Plasma Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates and Other Drug Classes), Treatment, Indication, End User and By Geography

調査会社Stratistics MRC社が発行したリサーチレポート（データ管理コード：SMRC23MA074）■ 発行会社/調査会社：Stratistics MRC
■ 商品コード：SMRC23MA074
■ 発行日：2022年12月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：約150
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール
■ 販売価格オプション（消費税別）
Single UserUSD4,150 ⇒換算￥630,800見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算￥1,140,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Stratistics MRC社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[出血性疾患検査のグローバル市場（～2027）：試薬、消耗品、器具、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Stratistics MRC社では、世界の出血性疾患検査市場規模が2022年に88.5百万ドルから2028年には155.08百万ドルになり、予測期間中にCAGR 9.7%で成長すると予測しています。本報告書では、出血性疾患検査の世界市場について幅広く分析し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、製品別（試薬、消耗品、器具、その他）分析、薬物クラス別（フィブリンシーラント、酢酸デスモプレシン、抗線溶薬、血漿由来凝固因子濃縮物、組換え凝固因子濃縮物、その他）分析、疾患別（フォン・ヴィレブランド病、血友病A、血友病B、その他）分析、エンドユーザー別（研究機関、病院、診療所、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、南米、中東・アフリカ）分析、最近の動向、企業情報など、以下の内容を掲載しています。なお、Sysmex Corporation, Siemens Healthcare GmbH, Alexion Pharmaceuticals, Abbott, Amgen Inc, F. Hoffmann-La Roche Ltd, Biogen Inc, Alnylam Pharmaceuticals Inc, Pfizer Inc, HORIBA Ltdなどの企業情報を含んでいます。
・エグゼクティブサマリー
・序論
・市場動向分析
・ファイブフォース分析
・世界の出血性疾患検査市場規模：製品別
- 試薬の市場規模
- 消耗品の市場規模
- 器具の市場規模
- その他製品の市場規模
・世界の出血性疾患検査市場規模：薬物クラス別
- フィブリンシーラントの市場規模
- 酢酸デスモプレシンの市場規模
- 抗線溶薬の市場規模
- 血漿由来凝固因子濃縮物の市場規模
- その他薬物クラスの市場規模
・世界の出血性疾患検査市場規模：疾患別
- フォン・ヴィレブランド病の市場規模
- 血友病Aの市場規模
- 血友病Bの市場規模
- その他疾患の市場規模
・世界の出血性疾患検査市場規模：エンドユーザー別
- 研究機関における市場規模
- 病院における市場規模
- 診療所における市場規模
- その他エンドユーザーにおける市場規模
・世界の出血性疾患検査市場規模：地域別
- 北米の出血性疾患検査市場規模
- ヨーロッパの出血性疾患検査市場規模
- アジア太平洋の出血性疾患検査市場規模
- 南米の出血性疾患検査市場規模
- 中東・アフリカの出血性疾患検査市場規模
・最近の動向
・企業情報

Stratistics MRCによると、世界の出血性疾患検査市場は2022年に8,850万ドルを占め、予測期間中の年平均成長率は9.7%で、2028年には1億5,508万ドルに達する見込みです。出血性疾患は、血液を凝固させる体内の能力が低下した場合に発生します。血栓は、血小板と特定の種類の血液細胞で構成され、感染した身体の一部に形成されます。この血栓は、血液中に細菌が侵入するのを防ぎ、傷ついた部分から血液が排出されるのを防ぎます。出血性疾患の検査では、特定の凝固因子が関与しているかどうかを判断し、血液が凝固するまでの時間を測定します。この検査では、切った血管が収縮するまでの時間と、血液中の血小板が穴を塞ぐまでの時間を評価します。

全米血友病財団によると、フォンウィルブランド病は最も一般的な出血性疾患であり、100人に1人、または米国人口の最大1％が罹患しています。

市場の主要プレーヤー

出血性疾患検査市場の主要企業には、Sysmex Corporation, Siemens Healthcare GmbH, Alexion Pharmaceuticals, Abbott, Amgen Inc, F. Hoffmann-La Roche Ltd, Biogen Inc, Alnylam Pharmaceuticals Inc, Pfizer Inc, HORIBA Ltd, Bayer AG, Xenetic Biosciences Inc, Thermo Fisher Scientific Inc, CSL Behring, Sanofi S.A, Catalyst Biosciences, Grifols, S.A, Octapharma Plasma, Inc, Bristol-Myers Squibb, Johnson & Johnson, Sun Pharma Industries Limited, Kedrion Biopharma Inc, Teva Pharmaceutical Industries Ltd, Takeda Pharmaceutical Company, Dimension Therapeutics Inc, Novo Nordisk A/S, Ferring Pharmaceuticalsが含まれます。

主な展開

2021年3月、F. Hoffmann La Roche Ltdは、スループットの最大化と検査効率の向上を目指し、Cobas pro統合ソリューションの8つの新しい構成を発売しました。

2020年2月、Novo Nordisk A/Sは、成人および小児の血友病A治療、すなわち手術中でも出血エピソードを減少させ、コントロールするための抗血友病因子製剤Esperoctを米国で発売しました。

対象製品
– 試薬
– 消耗品
– 器具
– その他の製品

対象薬剤
– フィブリンシーラント
– 酢酸デスモプレシン
– 抗線溶薬
– 血漿由来凝固因子濃縮製剤
– 遺伝子組換え凝固因子製剤
– その他の薬剤

対象となる治療
– ホルモン補充療法
– 避妊薬
– 血栓安定薬
– デスモプレシン
– フィブリンシーラント
– パイプライン分析
– 切り傷治療薬
– その他の治療薬

適応症
– フォンウィルブランド病
– 血友病A
– 血友病B
– その他の適応症

エンドユーザー
– 研究機関
– 病院
– クリニック
– その他のエンドユーザー

対象地域
– 北米
米国
カナダ
メキシコ
– ヨーロッパ
ドイツ
英国
イタリア
フランス
スペイン
その他のヨーロッパ
– アジア太平洋
日本
中国
インド
オーストラリア
ニュージーランド
韓国
その他のアジア太平洋地域
– 南米
アルゼンチン
ブラジル
チリ
その他の南米諸国
– 中東・アフリカ
サウジアラビア
アラブ首長国連邦
カタール
南アフリカ
その他の中東・アフリカ

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Bleeding Disorder Testing Market, By Product
5.1 Introduction
5.2 Reagents
5.3 Consumables
5.4 Instruments
5.5 Other Products
6 Global Bleeding Disorder Testing Market, By Drug Class
6.1 Introduction
6.2 Fibrin Sealants
6.3 Desmopressin Acetate
6.4 Antifibrinolytics
6.5 Plasma Derived Coagulation Factor Concentrates
6.6 Recombinant Coagulation Factor Concentrates
6.7 Other Drug Classes
7 Global Bleeding Disorder Testing Market, By Treatment
7.1 Introduction
7.2 Hormone Replacement Therapy
7.3 Contraceptives
7.4 Clot Stabilizing Drugs
7.5 Desmopressin
7.6 Fibrin Sealants
7.7 Pipeline Analysis
7.8 Drugs Applied To Cuts
7.9 Other Treatments
8 Global Bleeding Disorder Testing Market, By Indication
8.1 Introduction
8.2 Von Willebrand Disease
8.3 Hemophilia A
8.4 Hemophilia B
8.5 Other Indications
9 Global Bleeding Disorder Testing Market, By End User
9.1 Introduction
9.2 Research Institutes
9.3 Hospital
9.4 Clinics
9.5 Other End Users
10 Global Bleeding Disorder Testing Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Sysmex Corporation
12.2 Siemens Healthcare GmbH
12.3 Alexion Pharmaceuticals
12.4 Abbott
12.5 Amgen Inc
12.6 F. Hoffmann-La Roche Ltd
12.7 Biogen Inc
12.8 Alnylam Pharmaceuticals Inc.
12.9 Pfizer Inc
12.10 HORIBA Ltd
12.11 Bayer AG
12.13 Xenetic Biosciences Inc
12.12 Thermo Fisher Scientific Inc
12.14 CSL Behring
12.15 Sanofi S.A
12.16 Catalyst Biosciences
12.17 Grifols, S.A
12.18 Octapharma Plasma, Inc
12.19 Bristol-Myers Squibb
12.2 Johnson & Johnson
12.21 Sun Pharma Industries Limited
12.22 Kedrion Biopharma Inc
12.23 Teva Pharmaceutical Industries Ltd
12.24 Takeda Pharmaceutical Company
12.25 Dimension Therapeutics Inc
12.26 Novo Nordisk A/S
12.27 Ferring Pharmaceuticals
List of Tables
Table 1 Global Bleeding Disorder Testing Market Outlook, By Region (2020-2028) ($MN)
Table 2 Global Bleeding Disorder Testing Market Outlook, By Product (2020-2028) ($MN)
Table 3 Global Bleeding Disorder Testing Market Outlook, By Reagents (2020-2028) ($MN)
Table 4 Global Bleeding Disorder Testing Market Outlook, By Consumables (2020-2028) ($MN)
Table 5 Global Bleeding Disorder Testing Market Outlook, By Instruments (2020-2028) ($MN)
Table 6 Global Bleeding Disorder Testing Market Outlook, By Other Products (2020-2028) ($MN)
Table 7 Global Bleeding Disorder Testing Market Outlook, By Drug Class (2020-2028) ($MN)
Table 8 Global Bleeding Disorder Testing Market Outlook, By Fibrin Sealants (2020-2028) ($MN)
Table 9 Global Bleeding Disorder Testing Market Outlook, By Desmopressin Acetate (2020-2028) ($MN)
Table 10 Global Bleeding Disorder Testing Market Outlook, By Antifibrinolytics (2020-2028) ($MN)
Table 11 Global Bleeding Disorder Testing Market Outlook, By Plasma Derived Coagulation Factor Concentrates (2020-2028) ($MN)
Table 12 Global Bleeding Disorder Testing Market Outlook, By Recombinant Coagulation Factor Concentrates (2020-2028) ($MN)
Table 13 Global Bleeding Disorder Testing Market Outlook, By Other Drug Classes (2020-2028) ($MN)
Table 14 Global Bleeding Disorder Testing Market Outlook, By Treatment (2020-2028) ($MN)
Table 15 Global Bleeding Disorder Testing Market Outlook, By Hormone Replacement Therapy (2020-2028) ($MN)
Table 16 Global Bleeding Disorder Testing Market Outlook, By Contraceptives (2020-2028) ($MN)
Table 17 Global Bleeding Disorder Testing Market Outlook, By Clot Stabilizing Drugs (2020-2028) ($MN)
Table 18 Global Bleeding Disorder Testing Market Outlook, By Desmopressin (2020-2028) ($MN)
Table 19 Global Bleeding Disorder Testing Market Outlook, By Fibrin Sealants (2020-2028) ($MN)
Table 20 Global Bleeding Disorder Testing Market Outlook, By Pipeline Analysis (2020-2028) ($MN)
Table 21 Global Bleeding Disorder Testing Market Outlook, By Drugs Applied To Cuts (2020-2028) ($MN)
Table 22 Global Bleeding Disorder Testing Market Outlook, By Other Treatments (2020-2028) ($MN)
Table 23 Global Bleeding Disorder Testing Market Outlook, By Indication (2020-2028) ($MN)
Table 24 Global Bleeding Disorder Testing Market Outlook, By Von Willebrand Disease (2020-2028) ($MN)
Table 25 Global Bleeding Disorder Testing Market Outlook, By Hemophilia A (2020-2028) ($MN)
Table 26 Global Bleeding Disorder Testing Market Outlook, By Hemophilia B (2020-2028) ($MN)
Table 27 Global Bleeding Disorder Testing Market Outlook, By Other Indications (2020-2028) ($MN)
Table 28 Global Bleeding Disorder Testing Market Outlook, By End User (2020-2028) ($MN)
Table 29 Global Bleeding Disorder Testing Market Outlook, By Research Institutes (2020-2028) ($MN)
Table 30 Global Bleeding Disorder Testing Market Outlook, By Hospital (2020-2028) ($MN)
Table 31 Global Bleeding Disorder Testing Market Outlook, By Clinics (2020-2028) ($MN)
Table 32 Global Bleeding Disorder Testing Market Outlook, By Other End Users (2020-2028) ($MN)
Table 33 North America Bleeding Disorder Testing Market Outlook, By Country (2020-2028) ($MN)
Table 34 North America Bleeding Disorder Testing Market Outlook, By Product (2020-2028) ($MN)
Table 35 North America Bleeding Disorder Testing Market Outlook, By Reagents (2020-2028) ($MN)
Table 36 North America Bleeding Disorder Testing Market Outlook, By Consumables (2020-2028) ($MN)
Table 37 North America Bleeding Disorder Testing Market Outlook, By Instruments (2020-2028) ($MN)
Table 38 North America Bleeding Disorder Testing Market Outlook, By Other Products (2020-2028) ($MN)
Table 39 North America Bleeding Disorder Testing Market Outlook, By Drug Class (2020-2028) ($MN)
Table 40 North America Bleeding Disorder Testing Market Outlook, By Fibrin Sealants (2020-2028) ($MN)
Table 41 North America Bleeding Disorder Testing Market Outlook, By Desmopressin Acetate (2020-2028) ($MN)
Table 42 North America Bleeding Disorder Testing Market Outlook, By Antifibrinolytics (2020-2028) ($MN)
Table 43 North America Bleeding Disorder Testing Market Outlook, By Plasma Derived Coagulation Factor Concentrates (2020-2028) ($MN)
Table 44 North America Bleeding Disorder Testing Market Outlook, By Recombinant Coagulation Factor Concentrates (2020-2028) ($MN)
Table 45 North America Bleeding Disorder Testing Market Outlook, By Other Drug Classes (2020-2028) ($MN)
Table 46 North America Bleeding Disorder Testing Market Outlook, By Treatment (2020-2028) ($MN)
Table 47 North America Bleeding Disorder Testing Market Outlook, By Hormone Replacement Therapy (2020-2028) ($MN)
Table 48 North America Bleeding Disorder Testing Market Outlook, By Contraceptives (2020-2028) ($MN)
Table 49 North America Bleeding Disorder Testing Market Outlook, By Clot Stabilizing Drugs (2020-2028) ($MN)
Table 50 North America Bleeding Disorder Testing Market Outlook, By Desmopressin (2020-2028) ($MN)
Table 51 North America Bleeding Disorder Testing Market Outlook, By Fibrin Sealants (2020-2028) ($MN)
Table 52 North America Bleeding Disorder Testing Market Outlook, By Pipeline Analysis (2020-2028) ($MN)
Table 53 North America Bleeding Disorder Testing Market Outlook, By Drugs Applied To Cuts (2020-2028) ($MN)
Table 54 North America Bleeding Disorder Testing Market Outlook, By Other Treatments (2020-2028) ($MN)
Table 55 North America Bleeding Disorder Testing Market Outlook, By Indication (2020-2028) ($MN)
Table 56 North America Bleeding Disorder Testing Market Outlook, By Von Willebrand Disease (2020-2028) ($MN)
Table 57 North America Bleeding Disorder Testing Market Outlook, By Hemophilia A (2020-2028) ($MN)
Table 58 North America Bleeding Disorder Testing Market Outlook, By Hemophilia B (2020-2028) ($MN)
Table 59 North America Bleeding Disorder Testing Market Outlook, By Other Indications (2020-2028) ($MN)
Table 60 North America Bleeding Disorder Testing Market Outlook, By End User (2020-2028) ($MN)
Table 61 North America Bleeding Disorder Testing Market Outlook, By Research Institutes (2020-2028) ($MN)
Table 62 North America Bleeding Disorder Testing Market Outlook, By Hospital (2020-2028) ($MN)
Table 63 North America Bleeding Disorder Testing Market Outlook, By Clinics (2020-2028) ($MN)
Table 64 North America Bleeding Disorder Testing Market Outlook, By Other End Users (2020-2028) ($MN)
Table 65 Europe Bleeding Disorder Testing Market Outlook, By Country (2020-2028) ($MN)
Table 66 Europe Bleeding Disorder Testing Market Outlook, By Product (2020-2028) ($MN)
Table 67 Europe Bleeding Disorder Testing Market Outlook, By Reagents (2020-2028) ($MN)
Table 68 Europe Bleeding Disorder Testing Market Outlook, By Consumables (2020-2028) ($MN)
Table 69 Europe Bleeding Disorder Testing Market Outlook, By Instruments (2020-2028) ($MN)
Table 70 Europe Bleeding Disorder Testing Market Outlook, By Other Products (2020-2028) ($MN)
Table 71 Europe Bleeding Disorder Testing Market Outlook, By Drug Class (2020-2028) ($MN)
Table 72 Europe Bleeding Disorder Testing Market Outlook, By Fibrin Sealants (2020-2028) ($MN)
Table 73 Europe Bleeding Disorder Testing Market Outlook, By Desmopressin Acetate (2020-2028) ($MN)
Table 74 Europe Bleeding Disorder Testing Market Outlook, By Antifibrinolytics (2020-2028) ($MN)
Table 75 Europe Bleeding Disorder Testing Market Outlook, By Plasma Derived Coagulation Factor Concentrates (2020-2028) ($MN)
Table 76 Europe Bleeding Disorder Testing Market Outlook, By Recombinant Coagulation Factor Concentrates (2020-2028) ($MN)
Table 77 Europe Bleeding Disorder Testing Market Outlook, By Other Drug Classes (2020-2028) ($MN)
Table 78 Europe Bleeding Disorder Testing Market Outlook, By Treatment (2020-2028) ($MN)
Table 79 Europe Bleeding Disorder Testing Market Outlook, By Hormone Replacement Therapy (2020-2028) ($MN)
Table 80 Europe Bleeding Disorder Testing Market Outlook, By Contraceptives (2020-2028) ($MN)
Table 81 Europe Bleeding Disorder Testing Market Outlook, By Clot Stabilizing Drugs (2020-2028) ($MN)
Table 82 Europe Bleeding Disorder Testing Market Outlook, By Desmopressin (2020-2028) ($MN)
Table 83 Europe Bleeding Disorder Testing Market Outlook, By Fibrin Sealants (2020-2028) ($MN)
Table 84 Europe Bleeding Disorder Testing Market Outlook, By Pipeline Analysis (2020-2028) ($MN)
Table 85 Europe Bleeding Disorder Testing Market Outlook, By Drugs Applied To Cuts (2020-2028) ($MN)
Table 86 Europe Bleeding Disorder Testing Market Outlook, By Other Treatments (2020-2028) ($MN)
Table 87 Europe Bleeding Disorder Testing Market Outlook, By Indication (2020-2028) ($MN)
Table 88 Europe Bleeding Disorder Testing Market Outlook, By Von Willebrand Disease (2020-2028) ($MN)
Table 89 Europe Bleeding Disorder Testing Market Outlook, By Hemophilia A (2020-2028) ($MN)
Table 90 Europe Bleeding Disorder Testing Market Outlook, By Hemophilia B (2020-2028) ($MN)
Table 91 Europe Bleeding Disorder Testing Market Outlook, By Other Indications (2020-2028) ($MN)
Table 92 Europe Bleeding Disorder Testing Market Outlook, By End User (2020-2028) ($MN)
Table 93 Europe Bleeding Disorder Testing Market Outlook, By Research Institutes (2020-2028) ($MN)
Table 94 Europe Bleeding Disorder Testing Market Outlook, By Hospital (2020-2028) ($MN)
Table 95 Europe Bleeding Disorder Testing Market Outlook, By Clinics (2020-2028) ($MN)
Table 96 Europe Bleeding Disorder Testing Market Outlook, By Other End Users (2020-2028) ($MN)
Table 97 Asia Pacific Bleeding Disorder Testing Market Outlook, By Country (2020-2028) ($MN)
Table 98 Asia Pacific Bleeding Disorder Testing Market Outlook, By Product (2020-2028) ($MN)
Table 99 Asia Pacific Bleeding Disorder Testing Market Outlook, By Reagents (2020-2028) ($MN)
Table 100 Asia Pacific Bleeding Disorder Testing Market Outlook, By Consumables (2020-2028) ($MN)
Table 101 Asia Pacific Bleeding Disorder Testing Market Outlook, By Instruments (2020-2028) ($MN)
Table 102 Asia Pacific Bleeding Disorder Testing Market Outlook, By Other Products (2020-2028) ($MN)
Table 103 Asia Pacific Bleeding Disorder Testing Market Outlook, By Drug Class (2020-2028) ($MN)
Table 104 Asia Pacific Bleeding Disorder Testing Market Outlook, By Fibrin Sealants (2020-2028) ($MN)
Table 105 Asia Pacific Bleeding Disorder Testing Market Outlook, By Desmopressin Acetate (2020-2028) ($MN)
Table 106 Asia Pacific Bleeding Disorder Testing Market Outlook, By Antifibrinolytics (2020-2028) ($MN)
Table 107 Asia Pacific Bleeding Disorder Testing Market Outlook, By Plasma Derived Coagulation Factor Concentrates (2020-2028) ($MN)
Table 108 Asia Pacific Bleeding Disorder Testing Market Outlook, By Recombinant Coagulation Factor Concentrates (2020-2028) ($MN)
Table 109 Asia Pacific Bleeding Disorder Testing Market Outlook, By Other Drug Classes (2020-2028) ($MN)
Table 110 Asia Pacific Bleeding Disorder Testing Market Outlook, By Treatment (2020-2028) ($MN)
Table 111 Asia Pacific Bleeding Disorder Testing Market Outlook, By Hormone Replacement Therapy (2020-2028) ($MN)
Table 112 Asia Pacific Bleeding Disorder Testing Market Outlook, By Contraceptives (2020-2028) ($MN)
Table 113 Asia Pacific Bleeding Disorder Testing Market Outlook, By Clot Stabilizing Drugs (2020-2028) ($MN)
Table 114 Asia Pacific Bleeding Disorder Testing Market Outlook, By Desmopressin (2020-2028) ($MN)
Table 115 Asia Pacific Bleeding Disorder Testing Market Outlook, By Fibrin Sealants (2020-2028) ($MN)
Table 116 Asia Pacific Bleeding Disorder Testing Market Outlook, By Pipeline Analysis (2020-2028) ($MN)
Table 117 Asia Pacific Bleeding Disorder Testing Market Outlook, By Drugs Applied To Cuts (2020-2028) ($MN)
Table 118 Asia Pacific Bleeding Disorder Testing Market Outlook, By Other Treatments (2020-2028) ($MN)
Table 119 Asia Pacific Bleeding Disorder Testing Market Outlook, By Indication (2020-2028) ($MN)
Table 120 Asia Pacific Bleeding Disorder Testing Market Outlook, By Von Willebrand Disease (2020-2028) ($MN)
Table 121 Asia Pacific Bleeding Disorder Testing Market Outlook, By Hemophilia A (2020-2028) ($MN)
Table 122 Asia Pacific Bleeding Disorder Testing Market Outlook, By Hemophilia B (2020-2028) ($MN)
Table 123 Asia Pacific Bleeding Disorder Testing Market Outlook, By Other Indications (2020-2028) ($MN)
Table 124 Asia Pacific Bleeding Disorder Testing Market Outlook, By End User (2020-2028) ($MN)
Table 125 Asia Pacific Bleeding Disorder Testing Market Outlook, By Research Institutes (2020-2028) ($MN)
Table 126 Asia Pacific Bleeding Disorder Testing Market Outlook, By Hospital (2020-2028) ($MN)
Table 127 Asia Pacific Bleeding Disorder Testing Market Outlook, By Clinics (2020-2028) ($MN)
Table 128 Asia Pacific Bleeding Disorder Testing Market Outlook, By Other End Users (2020-2028) ($MN)
Table 129 South America Bleeding Disorder Testing Market Outlook, By Country (2020-2028) ($MN)
Table 130 South America Bleeding Disorder Testing Market Outlook, By Product (2020-2028) ($MN)
Table 131 South America Bleeding Disorder Testing Market Outlook, By Reagents (2020-2028) ($MN)
Table 132 South America Bleeding Disorder Testing Market Outlook, By Consumables (2020-2028) ($MN)
Table 133 South America Bleeding Disorder Testing Market Outlook, By Instruments (2020-2028) ($MN)
Table 134 South America Bleeding Disorder Testing Market Outlook, By Other Products (2020-2028) ($MN)
Table 135 South America Bleeding Disorder Testing Market Outlook, By Drug Class (2020-2028) ($MN)
Table 136 South America Bleeding Disorder Testing Market Outlook, By Fibrin Sealants (2020-2028) ($MN)
Table 137 South America Bleeding Disorder Testing Market Outlook, By Desmopressin Acetate (2020-2028) ($MN)
Table 138 South America Bleeding Disorder Testing Market Outlook, By Antifibrinolytics (2020-2028) ($MN)
Table 139 South America Bleeding Disorder Testing Market Outlook, By Plasma Derived Coagulation Factor Concentrates (2020-2028) ($MN)
Table 140 South America Bleeding Disorder Testing Market Outlook, By Recombinant Coagulation Factor Concentrates (2020-2028) ($MN)
Table 141 South America Bleeding Disorder Testing Market Outlook, By Other Drug Classes (2020-2028) ($MN)
Table 142 South America Bleeding Disorder Testing Market Outlook, By Treatment (2020-2028) ($MN)
Table 143 South America Bleeding Disorder Testing Market Outlook, By Hormone Replacement Therapy (2020-2028) ($MN)
Table 144 South America Bleeding Disorder Testing Market Outlook, By Contraceptives (2020-2028) ($MN)
Table 145 South America Bleeding Disorder Testing Market Outlook, By Clot Stabilizing Drugs (2020-2028) ($MN)
Table 146 South America Bleeding Disorder Testing Market Outlook, By Desmopressin (2020-2028) ($MN)
Table 147 South America Bleeding Disorder Testing Market Outlook, By Fibrin Sealants (2020-2028) ($MN)
Table 148 South America Bleeding Disorder Testing Market Outlook, By Pipeline Analysis (2020-2028) ($MN)
Table 149 South America Bleeding Disorder Testing Market Outlook, By Drugs Applied To Cuts (2020-2028) ($MN)
Table 150 South America Bleeding Disorder Testing Market Outlook, By Other Treatments (2020-2028) ($MN)
Table 151 South America Bleeding Disorder Testing Market Outlook, By Indication (2020-2028) ($MN)
Table 152 South America Bleeding Disorder Testing Market Outlook, By Von Willebrand Disease (2020-2028) ($MN)
Table 153 South America Bleeding Disorder Testing Market Outlook, By Hemophilia A (2020-2028) ($MN)
Table 154 South America Bleeding Disorder Testing Market Outlook, By Hemophilia B (2020-2028) ($MN)
Table 155 South America Bleeding Disorder Testing Market Outlook, By Other Indications (2020-2028) ($MN)
Table 156 South America Bleeding Disorder Testing Market Outlook, By End User (2020-2028) ($MN)
Table 157 South America Bleeding Disorder Testing Market Outlook, By Research Institutes (2020-2028) ($MN)
Table 158 South America Bleeding Disorder Testing Market Outlook, By Hospital (2020-2028) ($MN)
Table 159 South America Bleeding Disorder Testing Market Outlook, By Clinics (2020-2028) ($MN)
Table 160 South America Bleeding Disorder Testing Market Outlook, By Other End Users (2020-2028) ($MN)
Table 161 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Country (2020-2028) ($MN)
Table 162 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Product (2020-2028) ($MN)
Table 163 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Reagents (2020-2028) ($MN)
Table 164 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Consumables (2020-2028) ($MN)
Table 165 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Instruments (2020-2028) ($MN)
Table 166 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Other Products (2020-2028) ($MN)
Table 167 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Drug Class (2020-2028) ($MN)
Table 168 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Fibrin Sealants (2020-2028) ($MN)
Table 169 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Desmopressin Acetate (2020-2028) ($MN)
Table 170 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Antifibrinolytics (2020-2028) ($MN)
Table 171 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Plasma Derived Coagulation Factor Concentrates (2020-2028) ($MN)
Table 172 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Recombinant Coagulation Factor Concentrates (2020-2028) ($MN)
Table 173 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Other Drug Classes (2020-2028) ($MN)
Table 174 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Treatment (2020-2028) ($MN)
Table 175 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Hormone Replacement Therapy (2020-2028) ($MN)
Table 176 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Contraceptives (2020-2028) ($MN)
Table 177 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Clot Stabilizing Drugs (2020-2028) ($MN)
Table 178 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Desmopressin (2020-2028) ($MN)
Table 179 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Fibrin Sealants (2020-2028) ($MN)
Table 180 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Pipeline Analysis (2020-2028) ($MN)
Table 181 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Drugs Applied To Cuts (2020-2028) ($MN)
Table 182 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Other Treatments (2020-2028) ($MN)
Table 183 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Indication (2020-2028) ($MN)
Table 184 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Von Willebrand Disease (2020-2028) ($MN)
Table 185 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Hemophilia A (2020-2028) ($MN)
Table 186 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Hemophilia B (2020-2028) ($MN)
Table 187 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Other Indications (2020-2028) ($MN)
Table 188 Middle East & Africa Bleeding Disorder Testing Market Outlook, By End User (2020-2028) ($MN)
Table 189 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Research Institutes (2020-2028) ($MN)
Table 190 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Hospital (2020-2028) ($MN)
Table 191 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Clinics (2020-2028) ($MN)
Table 192 Middle East & Africa Bleeding Disorder Testing Market Outlook, By Other End Users (2020-2028) ($MN)



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 注意欠如・多動症（ADHD）のグローバル市場（～2027）：覚醒剤、非覚醒剤、その他
  • デジタルPCRのグローバル市場（～2027）：機器、試薬＆消耗品、その他
  • 脳腫瘍治療薬のグローバル市場（～2027）：標的療法、化学療法、免疫療法、その他
  • DNAフォレンジックのグローバル市場（～2027）：骨、毛髪、血液、その他
  • 生物学的種子処理のグローバル市場（～2027）：微生物、植物、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(SMRC23MA074 )"出血性疾患検査のグローバル市場（～2027）：試薬、消耗品、器具、その他" (英文：Bleeding Disorder Testing Market Forecasts to 2028 – Global Analysis By Product (Reagents, Consumables, Instruments and Other Products), Drug Class (Fibrin Sealants, Desmopressin Acetate, Antifibrinolytics, Plasma Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates and Other Drug Classes), Treatment, Indication, End User and By Geography)はStratistics MRC社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。